Kavita Praveen

8 Patents

• US125775622026

  Treatment of Glaucoma with Rho Guanine Nucleotide Exchange Factor 12 (ARHGEF12) Inhibitors

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US122586272025

  Kelch Domain Containing 7B (KLHDC7B) Variants and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US118651342024

  Treatment of Inflammation with Glucocorticoids and Angiopoietin-like 7 (ANGPTL7) Inhibitors

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US118459892023

  Treatment of Ophthalmic Conditions with Angiopoietin-like 7 (ANGPTL7) Inhibitors

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US118258192023

  Crnn Loss of Function Rodent Model

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US118209822023

  Treatment of Ophthalmic Conditions with Son of Sevenless 2 (SOS2) Inhibitors

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US117675262023

  Treatment of Ophthalmic Conditions with Angiopoietin-like 7 (ANGPTL7) Inhibitors

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US116741772023

  Kelch Domain Containing 7B (KLHDC7B) Variants and Uses Thereof

  Regeneron Pharmaceuticals, Inc.

  0 cites